Discover
DNA
Ginkgo Bioworks Holdings, Inc.
10.28
500 x undefined
800 x undefined
bid
ask
+
0.37
3.73%
650 @ 05:55 AM
10.31 +0.03 (0.29%)
| Ytd | 23.71% | |
| 1y | -9.51% |
9.90
day range
11.14
5.37
52 week range
17.58
| Open | 9.98 | Prev Close | 9.91 | Low | 9.90 | High | 11.14 | Mkt Cap | 671.54M |
| Vol | 1.45M | Avg Vol | 1.27M | EPS | -5.38 | P/E | N/A | Forward P/E | -1.19 |
| Beta | 1.10 | Short Ratio | 6.40 | Inst. Own | 68.36% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-06 | 50-d Avg | 8.71 | 200-d Avg | 9.33 | 1yr Est | 8.20 |
Earning
| Date | For | Estimate | Reported | Surprise | surprise % |
|---|---|---|---|---|---|
| 2024-11-12 | 2024-09 | -2.4 | -1.08 | 1.32 | 55.00% |
| 2024-08-08 | 2024-06 | -3.2 | N/A | N/A | N/A |
| 2024-08-08 | 2024-06 | -3.2 | -3.2 | N/A | N/A |
| 2024-05-09 | 2024-03 | -3.2 | N/A | N/A | N/A |
| 2024-05-09 | 2024-03 | -3.2 | -3.2 | N/A | N/A |
| 2024-02-29 | 2023-12 | -3.6 | -3.6 | N/A | N/A |
Upgrade / Downgrade
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| 2024-09-20 | TD Cowen | Upgrade | Buy | Buy |
| 2024-08-23 | BTIG | Upgrade | Sell | Sell |
| 2024-07-09 | Goldman Sachs | Upgrade | Sell | Sell |
| 2024-06-26 | BTIG | Upgrade | Sell | Sell |
| 2024-05-15 | BTIG | Downgrade | Neutral | Sell |
| 2024-05-15 | Morgan Stanley | Upgrade | Equal-Weight | Equal-Weight |
Profile
Ginkgo Bioworks Holdings, Inc., together with its subsidiaries, develops platform for cell programming in the United States. Its platform is used to program cells to enable biological production of products, such as novel therapeutics, food ingredients, and chemicals derived from petroleum. It serves pharma and biotech, agriculture, industrial and environment, food and nutrition, consumer and technology, and government and defense industries. Ginkgo Bioworks Holdings, Inc. was founded in 2008 and is headquartered in Boston, Massachusetts.
Insider Holder
| Date | Name | Relation | Quantity | Description |
|---|---|---|---|---|
| 2024-06-11 | BELLDEGRUN ARIE S | Director | 694.93K | Conversion of Exercise of derivative security |
| 2024-08-01 | COEN STEVEN P. | Officer | 207.32K | Sale |
| 2024-06-11 | DEKKERS MARIJN E | Director | 5.90M | Conversion of Exercise of derivative security |
| 2024-08-01 | DMYTRUK MARK E | Chief Financial Officer | 1.09M | Sale |
| 2024-06-11 | HANNAN KATHY HOPINKAH | Director | 167.25K | Conversion of Exercise of derivative security |
| 2024-06-11 | HENRY CHRISTIAN O | Director | 1.34M | Conversion of Exercise of derivative security |
Institution Ownership
| Report Date | Organization | Position | Value | Percentage |
|---|---|---|---|---|
| 2024-09-29 | Viking Global Investors, L.P. | 3.58M | 33.84M | 7.91% |
| 2024-09-29 | Baillie Gifford and Company | 3.36M | 31.77M | 7.43% |
| 2024-09-29 | Vanguard Group Inc | 2.61M | 24.65M | 5.77% |
| 2024-09-29 | Anchorage Capital Group, LLC | 1.75M | 16.52M | 3.86% |
| 2024-09-29 | Legal & General Group PLC | 1.43M | 13.53M | 3.16% |
| 2024-09-29 | Blackrock Inc. | 1.09M | 10.28M | 2.40% |
Fund Ownership
| Report Date | Organization | Position | Value | Percentage |
|---|---|---|---|---|
| 2024-09-29 | Vanguard Total Stock Market Index Fund | 1.17M | 11.06M | 2.59% |
| 2024-09-29 | Vanguard Extended Market Index Fund | 526.35K | 4.98M | 1.16% |
| 2024-09-29 | Vanguard Small-Cap Index Fund | 486.18K | 4.60M | 1.08% |
| 2024-08-30 | Vanguard U.S. Growth Fund | 465.80K | 4.41M | 1.03% |
| 2024-09-29 | Vanguard Small-Cap Growth Index Fund | 267.52K | 2.53M | 0.59% |
| 2024-10-30 | Exchange Traded Concepts Tr-Robo Global Artificial Intelligence ETF | 252.26K | 2.39M | 0.56% |
Split
| Split | Date |
|---|---|
| 1 : 40 | 2024-08-20 |
| 2 : 1 | 2004-05-13 |
| 2 : 1 | 2000-10-25 |
| 2 : 1 | 1999-11-03 |